All right reserved © immunoconcept.cnrs.fr 2022 by Nivo-Web
Publications Scientifiques
- Torri, A, Jaeger, J, Pradeu, T, Saleh, MC. The origin of RNA interference: Adaptive or neutral evolution?. PLoS Biol. 2022;20 (6):e3001715. doi: 10.1371/journal.pbio.3001715. PubMed PMID:35767561 PubMed Central PMC9275709.
- Blaye, C, Darbo, É, Debled, M, Brouste, V, Vélasco, V, Pinard, C et al.. An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy. ESMO Open. 2022;7 (4):100502. doi: 10.1016/j.esmoop.2022.100502. PubMed PMID:35759853 PubMed Central PMC9434232.
- Rosellini, P, Amintas, S, Caumont, C, Veillon, R, Galland-Girodet, S, Cuguillière, A et al.. Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer. Eur J Cancer. 2022;172 :85-95. doi: 10.1016/j.ejca.2022.05.026. PubMed PMID:35759814 .
- Seneschal, J, Boniface, K, Jacquemin, C. Alopecia areata: Recent advances and emerging therapies. Ann Dermatol Venereol. 2022; :. doi: 10.1016/j.annder.2022.03.006. PubMed PMID:35752494 .
- Chevalier, L, Cochet, H, Mahida, S, S, SB, Benard, A, Cariou, T et al.. Resuming Training in High-Level Athletes After Mild COVID-19 Infection: A Multicenter Prospective Study (ASCCOVID-19). Sports Med Open. 2022;8 (1):83. doi: 10.1186/s40798-022-00469-0. PubMed PMID:35751748 PubMed Central PMC9233721.
- Iaxx, R, Lefort, F, Domblides, C, Ravaud, A, Bernhard, JC, Gross-Goupil, M et al.. An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives. Ther Clin Risk Manag. 2022;18 :619-632. doi: 10.2147/TCRM.S251673. PubMed PMID:35677148 PubMed Central PMC9169675.
- Ravaioli, F, Zampieri, M, Morandi, L, Pirazzini, C, Pellegrini, C, De Fanti, S et al.. DNA Methylation Analysis of Ribosomal DNA in Adults With Down Syndrome. Front Genet. 2022;13 :792165. doi: 10.3389/fgene.2022.792165. PubMed PMID:35571061 PubMed Central PMC9094685.
- Galli, G, Vacher, P, Ryffel, B, Blanco, P, Legembre, P. Fas/CD95 Signaling Pathway in Damage-Associated Molecular Pattern (DAMP)-Sensing Receptors. Cells. 2022;11 (9):. doi: 10.3390/cells11091438. PubMed PMID:35563744 PubMed Central PMC9105874.